MARKET

VRTX

VRTX

Vertex Pharmaceuticals Inc
NASDAQ
421.16
-10.84
-2.51%
After Hours: 423.65 +2.49 +0.59% 18:40 05/14 EDT
OPEN
432.00
PREV CLOSE
432.00
HIGH
433.41
LOW
416.60
VOLUME
2.06M
TURNOVER
--
52 WEEK HIGH
519.88
52 WEEK LOW
377.85
MARKET CAP
108.15B
P/E (TTM)
-108.5772
1D
5D
1M
3M
1Y
5Y
1D
BBH: Fear Of Price Controls Is Not The Problem
Seeking Alpha · 9h ago
Parnassus Growth Equity Fund Q1 2025 Commentary
Seeking Alpha · 10h ago
Stifel Nicolaus Keeps Their Hold Rating on Vertex Pharmaceuticals (VRTX)
TipRanks · 10h ago
2 Biotech Stocks That Are Screaming Buys in May
The Motley Fool · 1d ago
This Stock Just Dropped by 12% in 1 Day. History Says This Will Happen Next
The Motley Fool · 1d ago
Fund Update: Capital Research Global Investors Just Disclosed New Holdings
NASDAQ · 2d ago
Innovation, pharma profits won't suffer under Trump prescription drug EO - White House
Seeking Alpha · 2d ago
Wynn Resorts, Microsoft, Palantir And A Health Care Stock On CNBC's 'Final Trades'
Benzinga · 2d ago
More
About VRTX
More
Vertex Pharmaceuticals Incorporated is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases, with a focus on specialty markets. It has seven approved medicines: five that treat the underlying cause of cystic fibrosis (CF), one that treats severe sickle cell disease (SCD) and transfusion dependent beta thalassemia (TDT), and one that treats moderate-to-severe acute pain. Its pipeline includes clinical-stage programs in CF, SCD, beta thalassemia, acute and peripheral neuropathic pain, APOL1-mediated kidney disease, IgA nephropathy and other autoimmune renal diseases and cytopenias, type 1 diabetes, myotonic dystrophy type 1, and autosomal dominant polycystic kidney disease. Its marketed medicines are TRIKAFTA/KAFTRIO (elexacaftor/tezacaftor/ivacaftor and ivacaftor), SYMDEKO/SYMKEVI (elexacaftor/tezacaftor/ivacaftor and ivacaftor), ORKAMBI (lumacaftor/ivacaftor), and KALYDECO (ivacaftor).
Recently
Symbol
Price
%Change

Webull offers Vertex Pharmaceuticals Inc stock information, including NASDAQ: VRTX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VRTX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading VRTX stock methods without spending real money on the virtual paper trading platform.